{"schema_version":"secwatch.filing_event.v1","accession":"0001615219-25-000069","form_type":"8-K","ticker":"DCOY","cik":"0001615219","company_name":"Decoy Therapeutics Inc.","filed_at":"2025-07-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.487446+00:00","generated_at":"2026-05-18T06:39:51.670796+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Salarius gets additional Nasdaq extension to late July 2025 for equity standard compliance","bullets":["Nasdaq Hearings Panel extended deadline to regain Equity Standard compliance to late July 2025.","Minimum Bid Price Requirement must be met by early August 2025.","On Jan 13, 2025, Salarius announced a merger agreement with Decoy Therapeutics; combined company to be named Decoy Therapeutics.","Failure to meet milestones could trigger delisting; previous deadline for equity standard was early July 2025.","Merger closing conditions remain; Decoy's CEO Rick Pierce will lead combined company."],"urls":{"canonical":"https://secwatch.observer/filing/0001615219-25-000069","json":"https://secwatch.observer/filing/0001615219-25-000069.json","markdown":"https://secwatch.observer/filing/0001615219-25-000069.md","text":"https://secwatch.observer/filing/0001615219-25-000069.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1615219/000161521925000069/0001615219-25-000069-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1615219/000161521925000069/flks-20250710.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T06:39:51.670796+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}